3,289
edits
Malignant Hyperthermia: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 23: | Line 23: | ||
[https://pubmed.ncbi.nlm.nih.gov/21169802/ Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice] | [https://pubmed.ncbi.nlm.nih.gov/21169802/ Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice] | ||
Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing | [https://pubs.asahq.org/anesthesiology/article/136/6/940/135870/Referral-Indications-for-Malignant-Hyperthermia Referral Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing] | ||
[https://www.bjanaesthesia.org/article/S0007-0912(22)00496-2/fulltext Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia] | [https://www.bjanaesthesia.org/article/S0007-0912(22)00496-2/fulltext Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia] | ||
| Line 30: | Line 30: | ||
[https://pubmed.ncbi.nlm.nih.gov/21791993/ New device simplifies workstation preparation for malignant hyperthermia-susceptible patients] | [https://pubmed.ncbi.nlm.nih.gov/21791993/ New device simplifies workstation preparation for malignant hyperthermia-susceptible patients] | ||
[https://www.bjanaesthesia.org/article/S0007-0912(23)00189-7/fulltext What is malignant hyperthermia susceptibility?] | |||
[https://pubmed.ncbi.nlm.nih.gov/37373564/ Real Evidence and Misconceptions about Malignant Hyperthermia in Children: A Narrative Review] | |||
[https://pubmed.ncbi.nlm.nih.gov/37787745/ Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program] | |||
[https://pubmed.ncbi.nlm.nih.gov/38329334/ Improving Dantrolene Mobilization in Regions with Limited Availability] | |||